scispace - formally typeset
D

Daniel L. Alkon

Researcher at West Virginia University

Publications -  314
Citations -  14681

Daniel L. Alkon is an academic researcher from West Virginia University. The author has contributed to research in topics: Protein kinase C & Associative learning. The author has an hindex of 61, co-authored 310 publications receiving 14036 citations. Previous affiliations of Daniel L. Alkon include National Institutes of Health & Woods Hole Oceanographic Institution.

Papers
More filters
Journal ArticleDOI

Accelerating the convergence of the back-propagation method

TL;DR: The back-propagation algorithm described by Rumelhart et al. (1986) can greatly accelerate convergence as discussed by the authors, however, in many applications, the number of iterations required before convergence can be large.
Journal ArticleDOI

Brain insulin receptors and spatial memory. Correlated changes in gene expression, tyrosine phosphorylation, and signaling molecules in the hippocampus of water maze trained rats.

TL;DR: The findings suggest that IR may participate in memory processing through activation of its receptor Tyr kinase activity, and they suggest possible engagement of Shc/Grb-2/Ras/mitogen-activated protein kinase cascades.
Journal ArticleDOI

Insulin and the insulin receptor in experimental models of learning and memory

TL;DR: Emerging evidence has suggested that insulin signaling plays a role in synaptic plasticity by modulating activities of excitatory and inhibitory receptors such as glutamate and GABA receptors, and by triggering signal transduction cascades leading to alteration of gene expression required for long-term memory consolidation.
Journal ArticleDOI

Internal Ca2+ mobilization is altered in fibroblasts from patients with Alzheimer disease.

TL;DR: Bombesin-induced Ca2+ release, which is inositol trisphosphate-mediated, is shown here to be greatly enhanced in AD fibroblasts compared with fibroBlasts from control groups, suggesting that the differences in bombesin and bradykinin responses in fibro Blasts and perhaps other cell types are likely to be due to alteration of inositl tr isphosphates-mediated release of intracellular Ca2+.
Journal ArticleDOI

Therapeutic effects of PKC activators in Alzheimer's disease transgenic mice.

TL;DR: Bryostatin 1 at subnanomolar concentrations dramatically enhances the secretion of the alpha-secretase product sAPP alpha in fibroblasts from AD patients, corroborate PKC and its activation as a potentially important means of ameliorating AD pathophysiology and perhaps cognitive impairment.